{"id":1815,"date":"2020-05-06T00:39:00","date_gmt":"2020-05-05T23:39:00","guid":{"rendered":"http:\/\/www.trendsandtargets.com\/?p=1815"},"modified":"2020-05-06T08:38:18","modified_gmt":"2020-05-06T07:38:18","slug":"hemogenyx-for-6-05-2020","status":"publish","type":"post","link":"http:\/\/www.trendsandtargets.com\/index.php\/2020\/05\/06\/hemogenyx-for-6-05-2020\/","title":{"rendered":"Hemogenyx for 6\/05\/2020"},"content":{"rendered":"

#CAC40 #Nasdaq<\/strong>The subject of a few emails, Hemogenyx share price has certainly been to the races. We’ve some concern regarding recent reversals, pointing to recent share price rises for this specialist in Blood Cancers turning into a rather painful ‘Pump and Dump’ experience. In this Covid-19 era, some of the victims shall not be those who contract the virus.<\/p>\n

At present, the share needs trade below 5.6p to provoke real panic as this risks triggering reversal to an initial 4.5p with secondary, if broken, down at a risking 0.75p, this being the point we cannot calculate below.<\/p>\n

Presently trading around 7.4p, the share price needs exceed 10p to give early indications of hope, this apparently allowing recovery again to an initial 11.25p with secondary, if bettered, working out at a longer-term (or later that day!) return to the 15p level. Only if this ambition is bettered dare we mention the potential of 17p and beyond, further down the road.<\/p>\n

 <\/p>\n

\"Hey,<\/span><\/span><\/p>\n

<\/a><\/span><\/span><\/p>\n

<\/a>FUTURES<\/span><\/span><\/span><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

Time Issued<\/span><\/p>\n<\/td>\n

\n

Market<\/span><\/p>\n<\/td>\n

\n

Price At Issue<\/span><\/p>\n<\/td>\n

\n

Short Entry<\/span><\/p>\n<\/td>\n

\n

Fast Exit<\/span><\/p>\n<\/td>\n

\n

Slow Exit<\/span><\/p>\n<\/td>\n

\n

Stop<\/span><\/p>\n<\/td>\n

\n

Long Entry<\/span><\/p>\n<\/td>\n

\n

Fast Exit<\/span><\/p>\n<\/td>\n

\n

Slow Exit<\/span><\/p>\n<\/td>\n

\n

Stop<\/span><\/p>\n<\/td>\n

\n

Prior<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

11:14:25PM<\/span><\/p>\n<\/td>\n

\n

BRENT<\/span><\/p>\n<\/td>\n

\n

32.18<\/span><\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\n

Success<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

11:16:29PM<\/span><\/p>\n<\/td>\n

\n

GOLD<\/span><\/p>\n<\/td>\n

\n

1706.16<\/span><\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
\n

11:26:43PM<\/span><\/p>\n<\/td>\n

\n

FTSE<\/span><\/p>\n<\/td>\n

\n

5831.47<\/span><\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\n

‘cess<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

11:29:02PM<\/span><\/p>\n<\/td>\n

\n

FRANCE<\/span><\/p>\n<\/td>\n

\n

4433<\/span><\/p>\n<\/td>\n

\n

4412<\/span><\/p>\n<\/td>\n

\n

4392<\/span><\/p>\n<\/td>\n

\n

4359<\/span><\/p>\n<\/td>\n

\n

4482<\/span><\/p>\n<\/td>\n

\n

4472<\/span><\/p>\n<\/td>\n

\n

4496.5<\/span><\/p>\n<\/td>\n

\n

4543<\/span><\/p>\n<\/td>\n

\n

4427<\/span><\/p>\n<\/td>\n

\n

Success<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

11:30:50PM<\/span><\/p>\n<\/td>\n

\n

GERMANY<\/span><\/p>\n<\/td>\n

\n

10658<\/span><\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\n

Success<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

11:32:54PM<\/span><\/p>\n<\/td>\n

\n

US500<\/span><\/p>\n<\/td>\n

\n

2872.57<\/span><\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\n

Success<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

11:36:01PM<\/span><\/p>\n<\/td>\n

\n

DOW<\/span><\/p>\n<\/td>\n

\n

23915.5<\/span><\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\n

Success<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

11:38:21PM<\/span><\/p>\n<\/td>\n

\n

NASDAQ<\/span><\/p>\n<\/td>\n

\n

8960<\/span><\/p>\n<\/td>\n

\n

8832<\/span><\/p>\n<\/td>\n

\n

8774<\/span><\/p>\n<\/td>\n

\n

8688<\/span><\/p>\n<\/td>\n

\n

8936<\/span><\/p>\n<\/td>\n

\n

8989<\/span><\/p>\n<\/td>\n

\n

9054.5<\/span><\/p>\n<\/td>\n

\n

9217<\/span><\/p>\n<\/td>\n

\n

8908<\/span><\/p>\n<\/td>\n

\n

Success<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

11:40:56PM<\/span><\/p>\n<\/td>\n

\n

JAPAN<\/span><\/p>\n<\/td>\n

\n

19573<\/span><\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\n

Success<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

5\/05\/2020 FTSE Closed at 5849 points. Change of 1.67%. Total value traded through LSE was: \u00a3 5,236,126,168 a change of -8.24%<\/h5>\n
4\/05\/2020 FTSE Closed at 5753 points. Change of -0.17%. Total value traded through LSE was: \u00a3 5,706,354,809 a change of 60.68%<\/h5>\n
1\/05\/2020 FTSE Closed at 5763 points. Change of -2.34%. Total value traded through LSE was: \u00a3 3,551,403,027 a change of -92.77%<\/h5>\n
30\/04\/2020 FTSE Closed at 5901 points. Change of -3.5%. Total value traded through LSE was: \u00a3 49,092,686,584 a change of 648.68%<\/h5>\n
29\/04\/2020 FTSE Closed at 6115 points. Change of 2.64%. Total value traded through LSE was: \u00a3 6,557,213,009 a change of 3.88%<\/h5>\n
28\/04\/2020 FTSE Closed at 5958 points. Change of 1.92%. Total value traded through LSE was: \u00a3 6,312,043,698 a change of 37.73%<\/h5>\n
27\/04\/2020 FTSE Closed at 5846 points. Change of 1.63%. Total value traded through LSE was: \u00a3 4,582,926,197 a change of -2.06%<\/span><\/h5>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

#CAC40 #NasdaqThe subject of a few emails, Hemogenyx share price has certainly been to the races. We’ve some concern regarding recent reversals, pointing to recent share price rises for this specialist in Blood Cancers turning into a rather painful ‘Pump and Dump’ experience. In this Covid-19 era, some of the victims shall not be those … <\/p>\n

Continue reading “Hemogenyx for 6\/05\/2020”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1815","post","type-post","status-publish","format-standard","hentry","category-trendsandtargets"],"_links":{"self":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts\/1815","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/comments?post=1815"}],"version-history":[{"count":1,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts\/1815\/revisions"}],"predecessor-version":[{"id":1816,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts\/1815\/revisions\/1816"}],"wp:attachment":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/media?parent=1815"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/categories?post=1815"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/tags?post=1815"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}